Mexico Pharmaceuticals Report - Q2 2025
I tiakina i:
| I whakaputaina i: | Fitch Solutions Country Industry Reports (Second Quarter 2025), p. 1 |
|---|---|
| I whakaputaina: |
Fitch Solutions Group Limited
|
| Ngā marau: | |
| Urunga tuihono: | Citation/Abstract Full Text - PDF |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
| Whakarāpopotonga: | Despite challenges in drug procurement and patent enforcement, Mexico's pharmaceutical industry is on track for sustained growth. This anticipated expansion is driven by rising demand for advanced chronic disease treatments. As the second largest pharmaceutical market in Latin America, Mexico presents significant opportunities for companies developing innovative medications. However, relatively low per capita spending on pharmaceuticals may limit the widespread adoption of patented drugs, potentially increasing the market share of generics. Government initiatives to enhance local drug manufacturing are likely to encourage more international partnerships, especially in technological exchange. |
|---|---|
| ISSN: | 2976-4750 |
| Puna: | ABI/INFORM Trade & Industry |